Skip to main content
HR 6930 116th Congress House

MADE in America Act of 2020

Official title: To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients… Show full official titleShow less

Official title: To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.

Introduced: June 18, 2020 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Health Administrative law and regulatory proceduresAdvanced technology and technological innovationsBuy American requirementsDepartment of Health and Human Services
More subjectsShow fewer subjects
Drug safety, medical device, and laboratory regulationForeign and international corporationsGovernment information and archivesGovernment studies and investigationsHealth technology, devices, suppliesIncome tax creditsIncome tax deductionsManufacturingPrescription drugsTaxation of foreign incomeTechnology assessmentWages and earnings
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 19, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 19, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 19, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Manufacturing API, Drugs, and Excipients in America Act of 2020 or the MADE in America Act of 2020

This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.

An eligible taxpayer may claim a tax credit equal to 30% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%.

In addition, the Food and Drug Administration shall continue a program to evaluate new drug manufacturing technologies included in an application for approval of a drug or biological product. The bill imposes various requirements on this program, including deadlines for evaluating such a technology.

Furthermore, the Department of Health and Human Services shall establish or expand programs to promote regulatory consistency and cooperation with drug regulatory authorities in other countries.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 8
All 8 Democratic 1 Republican 4
Rice, Tom
· Oct 1, 2020
Cartwright, Matt
· Jul 9, 2020
 R
Van Drew, Jefferson
New Jersey · Jun 18, 2020
 R
Westerman, Bruce
Arkansas · Jun 18, 2020
 R
Crawford, Eric A. "Rick"
Arkansas · May 19, 2020
 R
Griffith, H. Morgan
Virginia · May 19, 2020
McKinley, David
· May 19, 2020
 D
Soto, Darren
Florida · May 19, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6930: MADE in America Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6930/
MLA
"H.R. 6930: MADE in America Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6930/.
Bluebook (legal)
H.R. 6930, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6930/.
Markdown link
[H.R. 6930: MADE in America Act of 2020](https://openamerica.io/bill/116-HR-6930/)
Report a problem